| PIRS Stock | | | USD 16.84 0.07 0.42% |
Pieris Pharmaceuticals financial indicator trend analysis is much more than just breaking down Pieris Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pieris Pharmaceuticals is a good investment. Please check the relationship between Pieris Pharmaceuticals Total Operating Expenses and its Other Operating Expenses accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pieris Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Pieris Stock please use our
How to Invest in Pieris Pharmaceuticals guide.
Total Operating Expenses vs Other Operating Expenses
Total Operating Expenses vs Other Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Pieris Pharmaceuticals Total Operating Expenses account and
Other Operating Expenses. At this time, the significance of the direction appears to have totally related.
The correlation between Pieris Pharmaceuticals' Total Operating Expenses and Other Operating Expenses is 1.0. Overlapping area represents the amount of variation of Total Operating Expenses that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Pieris Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Pieris Pharmaceuticals' Total Operating Expenses and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Operating Expenses of Pieris Pharmaceuticals are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Total Operating Expenses i.e., Pieris Pharmaceuticals' Total Operating Expenses and Other Operating Expenses go up and down completely randomly.
Correlation Coefficient | 1.0 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Pieris Pharmaceuticals. It is also known as Pieris Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most indicators from Pieris Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pieris Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pieris Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Pieris Stock please use our
How to Invest in Pieris Pharmaceuticals guide.
Issuance Of Capital Stock is likely to gain to about 22.9
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 13.5
M in 2024.
Pieris Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Pieris Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pieris Pharmaceuticals fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Pieris Stock Analysis
When running Pieris Pharmaceuticals' price analysis, check to
measure Pieris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pieris Pharmaceuticals is operating at the current time. Most of Pieris Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Pieris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pieris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pieris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.